These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6290840)

  • 1. Receptors for PGI2 and PGD2 on human platelets.
    Siegl AM
    Methods Enzymol; 1982; 86():179-92. PubMed ID: 6290840
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3H-PGD2 binding by intact human platelets.
    Siegl AM; Smith JB; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1980; 6():395-7. PubMed ID: 6247889
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific binding sites for prostaglandin D2 on human platelets.
    Siegl AM; Smith JB; Silver MJ
    Biochem Biophys Res Commun; 1979 Sep; 90(1):291-6. PubMed ID: 227390
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
    Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin I2 receptors in a particulate fraction of platelets of various species.
    Schillinger E; Prior G
    Biochem Pharmacol; 1980 Sep; 29(17):2297-9. PubMed ID: 6252899
    [No Abstract]   [Full Text] [Related]  

  • 7. Agonist regulation of the human platelet prostaglandin D2 receptor.
    Cooper B
    Life Sci; 1979 Oct; 25(16):1361-7. PubMed ID: 230401
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of platelet receptors for prostaglandin I2 and D2.
    Schafer AI; Cooper B; O'Hara D; Handin RI
    J Biol Chem; 1979 Apr; 254(8):2914-7. PubMed ID: 218956
    [No Abstract]   [Full Text] [Related]  

  • 10. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs.
    Tynan SS; Andersen NH; Wills MT; Harker LA; Hanson SR
    Prostaglandins; 1984 May; 27(5):683-96. PubMed ID: 6087417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in prostacyclin platelet receptors in active spontaneous angina.
    Neri Serneri GG; Modesti PA; Fortini A; Abbate R; Lombardi A; Gensini GF
    Lancet; 1984 Oct; 2(8407):838-41. PubMed ID: 6148573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 14. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets.
    Ichikawa A; Mizuno Y; Hanasaki K; Yoshimura S; Tomita K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():671-2. PubMed ID: 3004152
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the multiplicity of platelet prostaglandin receptors. I. Evaluation of competitive antagonism by aggregometry.
    Andersen NH; Eggerman TL; Harker LA; Wilson CH; De B
    Prostaglandins; 1980 May; 19(5):711-35. PubMed ID: 6252573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM; Strange PG
    Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S; Whittle BJ
    Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.